-
S613754-25mg(+)-sulpiride.
-
-
S650099-1mg(+)-Syringaresinol, a lignan, is a NFAT transcription factor inhibitor, with an IC 50 of 329.4 μM. (+)-Syringaresinol also can be used for the research of lymphocytic leukemiaIn Vitro(+)-Syringaresinol inhibits the growth of P-388 cells, with an ED
-
S650099-5mg(+)-Syringaresinol, a lignan, is a NFAT transcription factor inhibitor, with an IC 50 of 329.4 μM. (+)-Syringaresinol also can be used for the research of lymphocytic leukemiaIn Vitro(+)-Syringaresinol inhibits the growth of P-388 cells, with an ED
-
T651180-10mg(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1.Form:SolidIC50&: Target:retinoic acid.
-
T651180-25mg(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1.Form:SolidIC50&: Target:retinoic acid.
-
T651180-50mg(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1.Form:SolidIC50&: Target:retinoic acid.
-
T651180-5mg(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1.Form:SolidIC50&: Target:retinoic acid.
-
T656566-1ml(+)-Talarozole is a potent inhibitor of retinoic acid metabolism extracted from patent WO 1997049704 A1.IC50&: Target:retinoic acid.
-
T162413-1g(+)-Terpinen-4-ol is an important constituent of tea tree oil, possessing antimycotic activity, which can be extracted from the leaves and flowers of Melaleuca alternifolia.
-
T162413-5g(+)-Terpinen-4-ol is an important constituent of tea tree oil, possessing antimycotic activity, which can be extracted from the leaves and flowers of Melaleuca alternifolia.
-